Sabby Management, Dara Biosciences
: In a new 13G filing just reported to the SEC, Hal Mintz's Sabby Management reported an 8.3% stake in DARA Biosciences Inc (NASDAQ:DARA
) stock. Due to the nature of the disclosure, Sabby is here as a passive investor, much as Alpha Capital Anstalt reported yesterday
. At market close, Alpha reported a slightly smaller 7.6% stake in Dara.
A couple of days earlier, Dara Biosciences announced it is entering into a Securities Purchase Agreement with several institutional investors, in which the company intends to sell 5.1 million shares in a direct offering. The price of the offering is set at $0.50 per share with gross proceeds amounting to almost $2.6 million, Dara Biosciences said in a statement.
Hirzel Capital Just Bought More Hawaiian Holdings Stock at $7.40/Share
Solus Alternative Asset Management Sells Some YRC Worldwide
How Warren Buffett’s ‘LeBron James Analogy’ Could Make You A Fortune